2021
DOI: 10.3390/molecules26185576
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells

Abstract: Over the last few years, much attention has been paid to phytocannabinoids derived from Cannabis for their therapeutic potential. Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the most abundant compounds of the Cannabis sativa L. plant. Recently, novel phytocannabinoids, such as cannabidibutol (CBDB) and cannabidiphorol (CBDP), have been discovered. These new molecules exhibit the same terpenophenolic core of CBD and differ only for the length of the alkyl side chain. Roles of CBD homologs in phys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Furthermore, neither the 4 or 7 carbon variants of CBD was found to have any greater impact on breast cancer cell growth than the 5-carbon molecule [ 41 ]. This could be due to the unique nature of CBG, which has been found to be an agonist of α2-adrenogeric receptors [ 42 ] and peroxisome proliferator-activated receptors (PPAR) α and γ [ 43 , 44 , 45 , 46 ], and the activation of these receptors has previously been reported to inhibit colorectal cancer cell growth.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, neither the 4 or 7 carbon variants of CBD was found to have any greater impact on breast cancer cell growth than the 5-carbon molecule [ 41 ]. This could be due to the unique nature of CBG, which has been found to be an agonist of α2-adrenogeric receptors [ 42 ] and peroxisome proliferator-activated receptors (PPAR) α and γ [ 43 , 44 , 45 , 46 ], and the activation of these receptors has previously been reported to inhibit colorectal cancer cell growth.…”
Section: Discussionmentioning
confidence: 99%
“…To detect the changes in intracellular ROS levels, 2′,7′-dichlorofluorescein diacetate (DCFH-DA, Sigma-Aldrich) staining was used. 31 DCFH-DA is a stable, fluorogenic, and non-polar compound that can readily diffuse into the cells and get deacetylated by intracellular esterases to a non-fluorescent 2′,7′-dichlorodihydrofluorescein (DCFH) which is later oxidized by intracellular ROS into highly fluorescent 2′,7′-dichlorofluorescein (DCF). The intensity of fluorescence is proportional to intracellular ROS levels.…”
Section: Methodsmentioning
confidence: 99%